#30DaysofTeal Recap
#30DaysofTeal Recap
Missed a day during #30DaysofTeal? Click the plus sign to see everything we did during the month of September!
News
Precision Medicine Initiative
Precision Medicine Initiative
In January’s State of the Union Address, President Obama ushered in an exciting phase in new medical research by introducing the Precision Medicine Initiative (PMI). This initiative will expand our understanding of personalized medicine, when doctors pick treatments to suit individual patients rather than the ‘one-size-fits-all’ approach. Since January, the President’s advisers have begun to … Continued
BRCA Mutations Confer Risk, Even in Absence of Family History
BRCA Mutations Confer Risk, Even in Absence of Family History
(October 15, 2015) According to a Japanese study published in Cancer, BRCA1/2 gene mutations may be associated with an inherited risk of ovarian cancer regardless of family history. The researchers examined 95 women with ovarian cancer who were treated from 2013 to 2015. BRCA1/2 gene mutation tests were performed with next-generation sequencing in order to determine a link … Continued
Third Party Spotlight
Third Party Spotlight
On December 30-January 1, golfers from across the US will tee off for the Second Annual Joan Kidd MD Ovarian Cancer Awareness Cup at Pebble Beach Golf Links, Pebble Beach, California. The 2016 Awareness Cup will celebrate the life work of Dr. Kidd, who lost her battle to ovarian cancer this summer. Dr. Kidd had a passion for raising ovarian cancer awareness and was a longtime volunteer to Shepherd’s Hope in Central Florida. Click the plus sign to register today.
Most Women Getting BRCA Test not Getting Genetic Counseling
Most Women Getting BRCA Test not Getting Genetic Counseling
(October 7, 2015) A report published in JAMA Oncology shows that most commercially insured women who underwent BRCA genetic testing did not receive genetic counseling by trained genetics professionals. Lack of clinician recommendation was the most commonly reported reason why they didn’t receive genetic counseling. The study authors examined the factors associated with use of … Continued
Partner Member Profile: Lydia's Legacy
When Lydia Greene Ross passed away after a courageous 3-year battle with uterine cancer, her daughter, Carin Ross Johnson, knew something had to be done to make sure that what happened to her mother didn’t happen to anyone else. At the time Lydia was diagnosed, very little awareness and visibility about gynecologic cancer existed. Carin … Continued
Hormone Replacement Therapy Beneficial to Ovarian Cancer Pa...
Hormone Replacement Therapy Beneficial to Ovarian Cancer Patients
(October 1, 2015) A new study published in the Journal of Clinical Oncology shows that women with the most common type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival. The 24-year, phase III international trial provides the strongest evidence yet that women with … Continued
Ovarian Cancer Endpoints at FDA
Ovarian Cancer Endpoints at FDA
By Annie Ellis: On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Click plus sign to read more.
Ovarian Cancer Endpoints Workshop hosted by the Food and Dr...
Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA)
By Annie Ellis On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the … Continued
#30DaysofTeal: Day 30
#30DaysofTeal: Day 30
This #30DaysofTeal, you helped us give ovarian cancer the spotlight over 1 million times-THANK YOU! But #30DaysofTeal doesn’t stop today…We Teal year round for the everyone affected by ovarian cancer, so keep spreading awareness and the Teal love.
#30DaysofTeal: Day 29
#30DaysofTeal: Day 29
Today we are excited to announce the creation of the Congressional Ovarian Cancer Caucus, a group of lawmakers in Washington, DC committed to advancing awareness and research in ovarian cancer. Please help us build this important movement and ask your Member of Congress to join the Caucus today. http://cqrcengage.com/ovarian/app/write-a-letter?7&engagementId=130619
#30DaysofTeal: Day 28
#30DaysofTeal: Day 28
Family history also contributes to a woman’s risk of ovarian cancer. Women who have one first-degree relative with ovarian cancer but no known genetic mutation still have an increased risk of developing ovarian cancer. The lifetime risk of a woman who has a first degree relative with ovarian cancer is five percent (the average woman’s … Continued